SGI
ATRS

Summit Global Investments’s Antares Pharma, Inc. ATRS Stock Holding History

Summit Global Investments’s Portfolio ATRS Stock Details ATRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-133,200
Closed -$485K – 653
2021
Q3 		$485K Buy
133,200
+16,700
+14% +$67.5K 0.04% 312
2021
Q2 		$508K Buy
+116,500
New +$475K 0.03% 358

Other funds holding ATRS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
FWSM
First Wilshire Securities Management Pasadena, California $444M AUM 42.88% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Amundi
Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

Summit Global Investments's ATRS Position: Q4 2021 in Review

Summit Global Investments sold out of Antares Pharma, Inc. (ATRS) in Q4 2021, closing a stake of 133,200 shares — an estimated $485K sold.

Summit Global Investments first reported a position in ATRS in Q2 2021 and held it in 2 quarters. The position peaked at $508K in Q2 2021. 162 funds tracked by Wall St. Rank hold ATRS as of Q4 2021.

  • Summit Global Investments reported no remaining Antares Pharma, Inc. position as of Q4 2021 after selling out during the quarter.
  • Summit Global Investments sold 133,200 Antares Pharma, Inc. shares in Q4 2021, an estimated $485K.
  • Summit Global Investments first reported a position in Antares Pharma, Inc. in Q2 2021 and held it in 2 quarters.
  • Summit Global Investments's Antares Pharma, Inc. position peaked at $508K in Q2 2021.
  • 162 funds tracked by Wall St. Rank held Antares Pharma, Inc. as of Q4 2021.

Based on Summit Global Investments's 13F filing for Q4 2021, filed 14 Feb 2022.